Biogen (BIIB)

Investing Cash Flow

-$5.32B

TTM · Period ending: · USD

BIIB logo

BIIB Investing Cash Flow

Latest reported-$5.32B
BIIB TTM Cash from Investing (-$29.50M → -$5.32B)
High-resolution chart · PNG

BIIB investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-5,315,500,000
-1,533,300,000
-1,371,100,000
-158,000,000
-1,304,000,000
-780,500,000
-799,200,000
-1,424,800,000
-1,983,400,000
-3,201,900,000
-4,088,700,000
-3,585,400,000
-161,300,000
1,284,200,000
1,589,000,000
1,617,200,000
-300,800,000
-1,147,000,000
-563,700,000
-617,400,000
-436,200,000
-1,116,200,000
-608,600,000
266,200,000
-47,300,000
674,600,000
470,500,000
-1,863,200,000
-2,116,400,000
-3,154,100,000
-2,046,300,000
-1,190,500,000
-1,818,200,000
-872,300,000
-2,963,100,000
-2,775,300,000
-1,492,300,000
-2,025,800,000
-2,484,800,000
-3,710,629,000
-4,736,829,000
-5,254,029,000
-4,553,629,000
-3,124,378,000
-2,674,942,000
-2,051,769,000
-1,542,976,000
-1,874,674,000
-1,658,502,000
-1,754,616,000
-1,604,668,000
-1,270,146,000
-1,468,144,000
-795,019,000
-950,342,000
-964,420,000
-1,029,207,000
-1,522,881,000
-1,650,294,000
-1,779,384,000
-1,261,961,000
-31,207,000
345,325,000
1,246,569,000
841,890,000
-53,588,000
-395,031,000
-1,243,410,000
-868,447,000
-907,156,000
-365,873,000
-516,751,000
-483,930,000
330,387,000
-286,572,000
266,385,000
454,525,000
-494,943,000
-599,773,000
-607,039,000
-1,262,824,000
150,243,000
417,741,000
288,892,000
657,258,000
-71,232,000
-382,428,000
-407,392,000
-289,724,000
-622,309,000
-400,742,000
-283,998,000
-284,136,000
-361,652,000
-289,510,000
-227,518,000
-247,725,000
-160,954,000
-252,915,000
-271,495,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.